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doi:10.1016/j.kjms.2010.11.002Abstract The mutations of survival motor neuron (SMN ) gene result in spinal muscular
atrophy (SMA), a common neurodegenerative disease. Some of the motor neurons undergoing
cell death is the predominant characteristic in SMA pathology. However, the viability and
sensitivity to stresses of other cell types also need to be determined. In this article, we es-
tablished HeLa stable cell line with inducible SMN knockdown to study its viability and sensi-
tivity to oxidative stress. SMN knockdown in the HeLa stable cell line was induced by
doxycycline. The proliferative and survival rates of SMN knockdown cells with or without
hydrogen peroxide (H2O2) treatment were determined. Our results showed that the prolifer-
ative rate of SMN knockdown cells decreased only slightly compared with that of the cellst of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung 807,
u.tw (Y.-F. Chang).
vier Taiwan LLC. All rights reserved.
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運動神經元存活without doxycycline treatment. In contrast, after H2O2 reached certain concentrations, the
survival rate of SMN knockdown cells decreased significantly. Our data indicate that SMN
knockdown alone is not critical to cell viability. However, when SMN knockdown cells are
under stress, such as oxidative stress, their survival rate may significantly decrease. Our
results will be helpful to prevent the detrimental effect caused by the cell death of non-
motor neurons under stress in SMA patients. In addition, the cell model we established can
be used to study the mechanism and screen drugs to prevent the detrimental effects in cases
of SMA disease.
摘要 Survival of motor neuron (SMN)基因突變會導致神經退化疾病：脊髓肌肉萎縮症(SMA)。有
些運動神經元細胞死亡是脊髓肌肉萎縮症的病理特徵。至於病患運動神經元以外其他類型細胞的
存活率及對壓力的敏感度則尚待深入研究，本文中，我們在HeLa細胞中建立誘導性基因減弱SMN
以研究這些細胞的存活率及對壓力的敏感度。以doxycycline誘導將HeLa細胞中的SMN基因減弱
後，再以H2O2處理觀察細胞增殖及存活率。我們的結果顯示SMN基因減弱的HeLa細胞與未加入
doxycycline的控制組相比，其細胞增殖率只輕微下降。相反的，細胞若經過H2O2處理，SMN基因
減弱的HeLa細胞其細胞存活率則顯著下降。我們的結果認為SMN基因減弱並非細胞存活的關鍵因
素，但是當細胞遭遇壓力如氧化壓力時，細胞存活率會顯著下降。我們的結果將有助於SMA病人
避免壓力造成非運動神經元細胞的傷害。此外，我們所建立的細胞模式將有助於SMA疾病的機制
研究及藥物篩選。
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Spinal muscular atrophy (SMA) is a common autosomal
recessive neurodegenerative disease characterized by the
degeneration of motor neurons in anterior horns of the
spinal cord, which leads to muscular paralysis and atrophy.
Molecular studies demonstrated that SMA is caused by
reduced expression of survival motor neuron (SMN)
proteins, resulting from mutations or deletion in SMN1 gene
in humans [1e3]. SMN proteins are the central component
of the SMN complexes, which are necessary for the
assembly of Sm proteins onto the small nuclear RNAs to
form small nuclear ribonucleoproteins (snRNPs). The
snRNPs are the essential components of the pre-mRNA
splicing machinery to catalyze the excision of introns in the
nucleus [4,5]. Depletion of SMN was reported to affect
snRNP assembly capacity and Cajal body formation [6,7].
Myoblast stable cell lines (C2C12) with SMN knockdown
showed a decrease in the number of nuclear gems, reduced
proliferation with no increase in cell death, defects in
myoblast fusion, and malformed myotubes [8].
Because SMA is caused by reduced SMN proteins, gene
knockdown is a powerful technique to study the role of SMN
in SMA. RNA interference (RNAi)-mediated knockdown of
SMN in HeLa cells results in decreased levels of Gemins,
such as Gemin 2, and disassembly of Cajal bodies [9,10].
Reduction of Drosophila SMN (dSMN) expression by RNAi
significantly increased apoptosis in Drosophila S2 cells [11].
Knockdown of SMN expression by RNAi also induced
apoptosis in differentiated P19 neural stem cells [12]. SMN
knockdown in PC12 cells changed the expression pattern of
Profilin II, resulting in altered cytoskeletal integrity and
a subsequent defect in neuritogenesis [13]. The short
interfering RNA (siRNA)-treated motor neuronelike NSC-34
cell line also showed decreased cell viability [14]. In addi-
tion, motor axonespecific pathfinding defects were found
in zebrafish embryos treated with antisense morpholinos to
reduce the SMN levels [15]. However, most of theseexperiments treated the cells with siRNA by transient
expression system, which makes it difficult to carry out
further studies. In this article, we established an inducible
stable SMN knockdown system in HeLa cells to study the
viability of cells under reduced SMN protein level.
Published neuropathological data indicated that some of
the motor neurons in SMA patients die by necrotic or
apoptotic cell death [16]. Reactive oxygen or nitrogen
species were reported to cause cell death by non-
physiological (necrotic) or regulated (apoptotic) pathways
[17]. In this article, we established HeLa stable cell line
with inducible SMN knockdown to study its viability and
sensitivity to oxidative stress. Our results showed that the
proliferative rate of SMN knockdown cells only slightly
decreased compared with that of the cells without doxy-
cycline treatment. In contrast, after hydrogen peroxide
(H2O2) reached certain concentrations, the survival rate of
SMN knockdown cells decreased significantly. Our data
indicate that SMN knockdown alone is not critical to cell
viability. However, when SMN knockdown cells are under
stress, such as oxidative stress, their survival rate may
decrease significantly. With this cell model, we demon-
strate that SMN participates in the cell death under
oxidative stress.
Materials and methods
SMN siRNA construct
The SMN siRNA construct is used to knockdown the SMN
protein. Double-stranded DNA for siRNAs targeting SMN genes
were inserted into inducible siRNA expression vector pSuper-
ior.neo (OligoEngine, Seattle, WA). The mRNA sequences tar-
geted by siRNA aremodified from those described by Shpargel
and Matera [10]. The protocols for pSuperior.neo-siSMN
construction followed the manufacturer’s instructions for
pSuperior RNAi system (OligoEngine). Briefly, two comple-
mentary oligonucleotides, 5’-GATCCCCGGAGCAAAACTTATC
Figure 1. Decreased survival of motor neuron (SMN) protein
levels induced by doxycycline in the HeLa stable cell line. HeLa
cells were cotransfected with pSuperior.neo-siSMN and
pcDNA6/TR and then selected by G418 and blasticidin. (A) The
selected stable cell line was treated with doxycycline from
0 ug/mL to 1 ug/mL to induce SMN protein knockdown. The
protein levels of SMN were analyzed 48 hours after doxycycline
treatment by Western blotting. The beta-actin proteins were
used as loading control. (B) The protein levels were quantified.
The error bars represent standard deviations calculated from
three independent experiments. Significant differences
between cells with and without doxycycline treatment are
shown (*p< 0.05, **p< 0.001). (C) The protein levels of the
HeLa stable cell line without doxycycline treatment and
normal HeLa cells with or without doxycycline treatment were
analyzed by Western blotting.
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and 5’-AGCTTTTCCAAAAAGGAGCAAAACTTATCTGACTCTCTTG
AAGTCAGATAAGTTTTGCTCCGGG-3’ were synthesized, an-
nealed, and inserted into pSuperior.neo between BglII and
HindIII sites. The correct clones were verified by double
digestions with EcoRI and HindIII. The construct we generated
was named pSuperior.neo-siSMN. The DNA sequence was
verified by sequencing.
Cell culture
HeLa cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM), supplemented with 10% fetal bovine
serum, and antibiotics. Ten micrograms of both pSuper-
ior.neo-siSMN and pcDNA6/TR (Invitrogen, Carlsbad, CA)
were cotransfected into HeLa cells by electroporation. The
cells were then selected with 500 mg/mL G418 and 2 mg/mL
blasticidin for clones with stably transfected pSuper-
ior.neo-siSMN and pcDNA6/TR.
Western blotting
Western blotting is used to detect the protein levels of SMN
and controlled beta-actin. Cells were harvested and lysed
in RIPA buffer (50 mM Tris-HCl, pH 8; 1 mM EDTA; 150 mM
NaCl; 1% nonidet P40 (NP40); 0.5% sodium deoxycholate; 1%
sodium dodecyl sulfate (SDS), 1 protease inhibitor cock-
tails; and 1 mM phenylmethylsulfonyl fluoride (PMSF)) at
4C for 20 minutes. The lysates were subjected to sodium
dodecyl sulfate- polyacrylamide gel electrophoresis (SDS-
PAGE) and immunoblotting. The blots were probed with
anti-SMN antibody (BD Biosciences, Frankin Lakes, NJ) or
anti-beta-actin antibody (Santa Cruz, Santa Cruz, CA) and
detected by ECL chemiluminescence kit (GE Healthcare,
Little Chalfont, UK).
Cell proliferation assay
The cell proliferation assay is used to calculate the cell
number after proliferation. The selected HeLa cells with
doxycycline (Sigma, St. Louis, MO) treatment represented
the cells with SMN knockdown. The cells without doxycy-
cline treatment were used as the control. 1 104 cells were
cultured in 6-cm dishes for 12 hours and then induced with
doxycycline (1 mg/mL) each alternate day. The cells were
then incubated at 37C from 0 days to 6 days, and the
numbers were counted.
Cell survival assay
The cell survival assay is used to calculate the number of
surviving cells after H2O2 treatment. The selected HeLa
cells with doxycycline treatment represented the cells
with SMN knockdown. The cells without doxycycline
treatment were used as the control. The cell survival
assays were performed by CellTiter 96 Aqueous One
Solution (Promega, Madison, WI). The protocols were
according to the technical bulletin for CellTiter 96
Aqueous One Solution. Briefly, 1,000 cells were cultured in
96-well plates for 12 hours and then induced with doxy-
cycline (1 mg/mL) for a further 48 hours. The cells werethen treated with H2O2 for 24 hours. Twenty microliters of
CellTiter 96 Aqueous One Solution Reagent was added to
each well and incubated at 37C for 1 hour. Finally, the
absorbance of 490 nm was measured.
Results
Inducible knockdown of SMN protein in HeLa cells
To gain insight into the functions of SMN, we tried to
establish a cell system with inducible knockdown of SMN
protein. Double-stranded DNA for siRNAs targeting SMN
genes was inserted into inducible siRNA expression vector
pSuperior.neo. The construct that we generated was named
as pSuperior.neo-siSMN. Tetracycline repressor encoded
from pcDNA6/TR depressed the expression of siRNAs in the
absence of tetracycline or doxycycline. The pSuperior.neo-
siSMN and pcDNA6/TR were cotransfected into HeLa cells.
The cells were then selected with Genetisin (G418) and
blasticidin for clones with stably transfected pSuper-
ior.neo-siSMN and pcDNA6/TR. Stable cell lines were then
treated with doxycycline from 0.1 mg/mL to 1 mg/mL to
induce SMN knockdown. It was reported that SMN protein
levels decreased after 44e60 hours with SMN RNAi [9,10].
H2O2 decreases SMN knockdown cells survival 105The SMN protein levels of stable cell lines were then
detected 48 hours after doxycycline treatment by Western
blotting with anti-SMN antibody. The SMN protein level in
one of the stable clones was knocked down successfully by
doxycycline treatment (Fig. 1A). The results showed that
the SMN protein levels decreased to 42% and 5.4% of normal
cells with 0.5 mg/mL and 1.0 mg/mL doxycycline treatment,
respectively (Fig. 1B). This indicated that the extent of SMN
knockdown depended on the concentration of doxycycline,
and that the best concentration of doxycycline to knock
down SMN was 1 mg/mL. We then treated this cell line with
1 mg/mL doxycycline for the remaining experiments. The
SMN level of this HeLa stable cell line without doxycycline
treatment was similar to normal HeLa cells with or without
doxycycline treatment (Fig. 1C). These data demonstrated
that we had successfully established a HeLa cell model with
inducible knockdown of SMN expression.
The proliferative rate of cells with reduced SMN
protein level was not significantly changed
Motor neurons with reduced SMN protein in SMA patients
were reported to die by apoptotic or necrotic cell death.
We then analyzed the viable cell number to study the
viability of the cells we established under SMN knockdown.
We treated the HeLa stable cell line with doxycycline each
alternate day to decrease the SMN protein level. The
proliferative rates of cells were then analyzed by cell
number counting. This experiment was repeated three
times. The results showed that the proliferative rate of
cells with reduced SMN protein level decreased only
slightly compared with that of the cells without doxycy-
cline treatment (Fig. 2). The difference between the cells
with or without SMN knockdown did not reachFigure 2. The proliferative rate was not significantly
changed in doxycycline-induced SMN knockdown cells. 1 104
cells of the HeLa stable cell line were treated with 1 ug/mL
doxycycline to induce survival motor neuron (SMN) protein
knockdown. The cells without doxycycline treatment were
used as control. The proliferative rates of cells were then
analyzed by counting the number of cells. The cell numbers
were counted everyday. This experiment was repeated three
times. The error bars represent standard deviations calculated
from three independent experiments. The slight decrease in
doxycycline-induced SMN knockdown cells did not reach
a statistically significant level by T test analysis (p> 0.05).a statistically significant level by T test analysis. These
data indicate that reduced SMN protein level alone may
not be critical to cell viability in some cell types, such as
HeLa cells.
The survival rate of cells with reduced SMN protein
level significantly decreased under oxidative stress
Because reduced SMN protein level alone may not be crit-
ical to cell viability, we further investigated other factors
that may increase the cell death of SMN knockdown cells.
Oxidative damage was reported to be the major cause for
neuronal loss [18]. We then tested whether H2O2 increased
the cell death of SMN knockdown cells. After induction by
doxycycline, the SMN knockdown HeLa cells were treated
with H2O2 from 0.01 mM to 6 mM for 24 hours (Fig. 3). This
experiment was repeated three times. The results demon-
strated that treatment with 0.01 mM, 0.25 mM, and 0.5 mM
H2O2 did not cause significant difference in viabilities
between cells with and without SMN knockdown. However,
the survival rate of the cells with reduced SMN protein level
significantly decreased with 0.75 mM and 1 mM H2O2
treatment. Moreover, almost all of the cells were dead
when the concentration of H2O2 reached 6 mM (Fig. 3).
These results indicate that certain concentrations of H2O2
increase the cell death of SMN knockdown cells.
Discussion
The fibroblasts from SMA patients are popular non-motor
neurons cells used in SMN studies [19,20]. However, to
collect fibroblasts is an invasive process for SMA patients. In
addition, after the fibroblasts were cultured, the survival ofFigure 3. The survival rate significantly decreased in SMN
knockdown cells with H2O2 treatment. Thousands of the HeLa
stable cell line were cultured in 96-well plates and treated
with doxycycline. The cells without doxycycline treatment
were used as control. The cells were then treated with
hydrogen peroxide from 0 mM to 6 mM for 24 hours. The cell
survival assays were performed by CellTiter 96 Aqueous One
Solution (Promega). Twenty microliters of CellTiter 96 Aqueous
One Solution Reagent was added to each well, and the absor-
bance of 490 nm was measured. The values plotted in Y-axis
represent the absorbent percentage of control without
hydrogen peroxide treatment. The error bars represent stan-
dard deviations calculated from three independent experi-
ments. Significant differences between doxycycline-treated
and control cells are shown (*p< 0.001).
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establish a cell model will be convenient for some of the
preliminary data collection. SMA is characterized by
reduced expression of SMN proteins. Gene knockdown is
a powerful technique to study the role of SMN in SMA.
However, most of the articles published to study SMA with
RNA interference used transient expression systems, and it
is difficult to perform long-term studies with these tran-
sient expression systems. The stable knockdown cells can
be used for long-term studies. In this article, we success-
fully established a stably inducible SMN knockdown cell
model system. Different SMN protein levels were induced
by 0.5 ug/mL and 1 ug/mL doxycycline. This indicates that,
with this cell model, the SMN protein level can be knocked
down to certain ranges by different concentrations of
doxycycline. The cells with different levels of SMN proteins
will be useful for SMN functional studies.
The data in Fig. 2 showed that the proliferative rate of
cells with reduced SMN proteins only slightly decreased in
HeLa cells. However, Tru¨zsch et al. [12] showed that when
SMN gene expression was knocked down in the differen-
tiated P19 cells, it showed a dramatic increase in the
percentage of apoptotic cells but not in the undifferenti-
ated cells. It is, therefore, likely that SMN knockdown in
different cell types results in different effects. HeLa cells
may represent some non-motor neurons cell types. It is
possible that the non-motor neurons cells of SMA patients
are weaker than those of normal people especially under
certain conditions. Our data in Figs. 2 and 3 show that
reduced SMN protein level only slightly decreased the
proliferative rate in HeLa cells. However, H2O2 dramati-
cally increased the cell death of SMN knockdown cells. The
cell viability of HeLa treated with H2O2 in our experiment
is also similar to previous results with or without doxycy-
cline [21e23]. These results demonstrated that some of
the non-motor neurons cells in SMA patients may be
normal in phenotype, but they are vulnerable under
stresses, such as oxidative stress. Oxidative stress has
been reported to be one of the predisposing factors in the
pathogenesis of motor neuron diseases, including amyo-
trophic lateral sclerosis and Parkinson’s disease [24e26].
Our results show that SMN plays an important role in non-
neuronal cells under stressed conditions. It is still possible
that motor neurons are also very sensitive under stresses,
and the sensitivity to stresses of motor neurons is one of
the major causes of the dysfunction in SMA patients.
However, our results may be helpful to prevent some
detrimental effects in SMA patients caused by defects in
non-motor neurons. For example, it may be wise to advise
SMA patients to avoid stresses, such as oxidative stress, in
their daily health care.
Reactive oxygen speciesegenerating agents, such as
H2O2, menadione, and beta-lapachone, induce oxidative
stress that inactivates the activity of SMN complex [27]. In
addition, overexpressed SMN proteins protect cells against
mutant superoxide dismutase 1 toxicity [28]. Superoxide
dismutase 1 is an enzyme that is essential for scavenging of
superoxide radicals. Thus, SMN may play a role in oxidative
stress pathophysiology. Our data in Fig. 3 demonstrate that
SMN participates in the cell death under H2O2 in vivo.
Overall, we successfully generated a cell model system
with inducible SMN knockdown. With this cell model, wedemonstrate that SMN participates in the cell death under
oxidative stress. These findings may be helpful to prevent
SMA patients from some detrimental effects. In addition to
mechanistic studies, this cell model may be used for drug-
screening assay to select the drugs that can improve the
function of the cells with low levels of SMN protein. Our cell
model may be a promising resource for studies on the
mechanisms and clinical applications of SMA.
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